General form of registration statement for all companies including face-amount certificate companies

Temporary Equity and Stockholders' Deficiency (Tables)

v3.19.3.a.u2
Temporary Equity and Stockholders' Deficiency (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2019
Dec. 31, 2018
Equity [Abstract]    
Summary of Warrants Activity

A summary of warrants activity during the nine months ended September 30, 2019 is presented below:

 

    Number of Warrants     Weighted Average Exercise Price     Weighted Average Remaining Life in Years     Intrinsic Value  
                         
Outstanding, December 31, 2018     1,229,630       2.15                  
Issued     -       -                  
Exercised     -       -                  
Cancelled     (364,639 )     2.12                  
Expired     (237,587 )     2.30                  
Outstanding, September 30, 2019     627,404     $            2.11       1.4     $              -  
                                 
Exercisable, September 30, 2019     627,404     $ 2.11       1.4     $ -  

A summary of warrants activity during the years ended December 31, 2018 and 2017 is presented below:

 

    Number of Warrants     Weighted Average Exercise Price     Weighted Average Remaining Life in Years     Intrinsic Value  
Outstanding, December 31, 2016     1,901,480     $ 2.20                  
Issued     2,250            2.00                  
Exercised     -       -                  
Cancelled     (438,434 )     2.30                  
Outstanding, December 31, 2017     1,465,296       2.17                  
Issued     -                          
Exercised     -                          
Cancelled     (235,666 )     2.30                  
Outstanding, December 31, 2018     1,229,630     $ 2.15       1.9     $ -  
                                 
Exercisable, December 31, 2018     1,229,630     $ 2.15       1.9     $ -  

Schedule of Fair Value Assumption of Warrants  

Risk free interest rate     1.92 %
Expected term (years)     5.00  
Expected volatility     44.0 %
Expected dividends     0.0 %
Forfeiture rate     5.0 %

Schedule of Share-based Compensation, Equity Instruments Other Than Options, by Exercise Price Range

A summary of outstanding and exercisable warrants as of September 30, 2019 is presented below:

 

Warrants Outstanding     Warrants Exercisable  
Exercise Price     Exercisable Into   Outstanding Number of Warrants     Weighted Average Remaining
Life in Years
    Exercisable Number of Warrants  
                         
$ 2.00     Common Stock     479,651       1.4       479,651  
$ 2.30     Common Stock     21,462       0.3       21,462  
$ 2.50     Common Stock     126,291       1.5       126,291  
        Total     627,404               627,404  

A summary of outstanding and exercisable warrants as of December 31, 2018 is presented below:

 

Warrants Outstanding     Warrants Exercisable  
Exercise Price     Exercisable Into   Outstanding Number of Warrants     Weighted Average Remaining Life in Years     Exercisable Number of Warrants  
$      2.00     Common Stock     741,879           2.0       741,879  
$ 2.30     Common Stock     299,444       0.5       299,444  
$ 2.50     Common Stock     188,307       2.2       188,307  
        Total     1,229,630               1,229,630  

Schedule of Fair Value Assumptions of Stock Option

The Company has computed the fair value of options granted using the Black-Scholes option pricing model. Assumptions used in applying the Black-Scholes option pricing model during the nine months ended September 30, 2019 are as follows:

 

    For the Nine Months Ended  
    September 30,  
    2019     2018  
             
Risk free interest rate     2.43 %     2.56 - 2.96 %
Expected term (years)     3.6 - 5.0       3.6 - 5.0  
Expected volatility     52 %     44 %
Expected dividends     0.00 %     0.00 %

Assumptions used in applying the Black-Scholes option pricing model during years ended December 31, 2018 and 2017, respectively, are as follows:

 

    For the Years Ended  
    December 31,  
    2018     2017  
Risk free interest rate     2.96 %     2.06 %
Expected term (years)     3.6 - 5.0       3.5-4.5  
Expected volatility     43.53 %     42.30 %
Expected dividends     0.00 %     0.00 %

Schedule of Share-based Compensation, Stock Options, Activity

The following table represents activity related to options for the purchase of GGH common stock during the nine months ended September 30, 2019 is presented below:

 

          Weighted     Weighted        
          Average     Average        
    Number of     Exercise     Remaining     Intrinsic  
    Options     Price     Term (Yrs)     Value  
                         
Outstanding, December 31, 2018     9,499,265       1.65                  
Granted     4,489,890       0.39                  
Exercised     -       -                  
Expired     (992,375 )     2.38                  
Forfeited     (3,364,890 )     2.24                  
Outstanding, September 30, 2019     9,631,890     $ 0.78       3.8     $ 426,540  
                                 
Exercisable, September 30, 2019     2,465,142     $ 1.46       2.6     $ -  

A summary of options activity during the years ended December 31, 2018 and 2017 is presented below:

 

    Number of Options     Weighted Average Exercise Price     Weighted Average Remaining Life in Years     Intrinsic Value  
                         
Outstanding, December 31, 2016     8,024,265              2.39                  
Granted     1,395,000       1.10                  
Exercised     -       -                  
Expired     (75,000 )     3.85                  
Forfeited     (110,000 )     2.39                  
Outstanding, December 31, 2017     9,234,265       2.18                  
Granted     2,830,000       0.65                  
Exercised     -       -                  
Expired     (2,505,000 )     2.49                  
Forfeited     (60,000 )     1.62                  
Outstanding, December 31, 2018     9,499,265     $ 1.65       2.5     $ -  
                                 
Exercisable, December 31, 2018     5,232,035     $ 2.25       1.3     $ -  

Schedule of Share-based Compensation, Shares Outstanding Under Stock Option Plans, by Exercise Price Range

The following table presents information related to options for the purchase of GGH common stock at September 30, 2019:

 

Options Outstanding     Options Exercisable  
Exercise Price     Outstanding Number of Options     Weighted Average Remaining
Life in Years
    Exercisable Number of Options  
                     
$ 0.39       4,489,890       -       -  
$ 0.54       1,500,000       4.0       375,000  
$ 0.77       1,320,000       3.4       495,002  
$ 1.10       1,070,000       3.1       468,140  
$ 2.20       1,242,000       1.5       1,117,000  
$ 3.30       10,000       0.7       10,000  
          9,631,890       2.6       2,465,142  

The following table presents information related to stock options as of December 31, 2018:

 

Options Outstanding     Options Exercisable  
Exercise
Price
    Outstanding
Number of
Options
    Weighted
Average
Remaining Life
in Years
    Exercisable
Number of
Options
 
                     
$ 0.54       1,500,000       -       0  
$ 0.77       1,320,000       -       0  
$ 1.10       1,370,000            3.9       342,500  
$ 2.20       3,071,890       1.5       2,679,160  
$ 2.48       2,237,375       0.7       2,210,375  
          9,499,265       1.3       5,232,035